Faron Pharmaceuticals Oy (LON:FARN - Get Free Report) shares passed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of GBX 182.05 ($2.40) and traded as high as GBX 221 ($2.92). Faron Pharmaceuticals Oy shares last traded at GBX 215 ($2.84), with a volume of 2,900 shares traded.
Faron Pharmaceuticals Oy Price Performance
The stock has a fifty day moving average of GBX 182.05 and a two-hundred day moving average of GBX 154.47. The stock has a market capitalization of £224.93 million, a price-to-earnings ratio of -671.88 and a beta of 0.36. The company has a current ratio of 1.45, a quick ratio of 1.09 and a debt-to-equity ratio of 922.55.
About Faron Pharmaceuticals Oy
(
Get Free Report)
Faron Pharmaceuticals Oy operates as a clinical stage drug discovery and development company. The company's lead product candidates are Traumakine, an investigational intravenous interferon beta-1a therapy for the prevention from cytokine release syndrome (CRS), or ischemia and hyperinflammatory conditions; and Bexmarilimab, a novel anti-Clever-1 humanized antibody that targets a subpopulation of tumor-associated macrophages and converts the highly immunosuppressive M2-like macrophages to a pro-inflammatory state to promote immune activation.
Featured Articles
Before you consider Faron Pharmaceuticals Oy, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Faron Pharmaceuticals Oy wasn't on the list.
While Faron Pharmaceuticals Oy currently has a "hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
